Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022.
作者信息
Shankar Divya A, Hawkins Finn, Alysandratos Konstantinos-Dionysios, Wilson Kevin C, Walkey Allan J, Bosch Nicholas A, Law Anica C
机构信息
Boston University School of Medicine Boston, Massachusetts.
出版信息
Ann Am Thorac Soc. 2024 Jan;21(1):170-173. doi: 10.1513/AnnalsATS.202308-697RL.
Abstract
摘要
相似文献
1
Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022.
Ann Am Thorac Soc. 2024 Jan;21(1):170-173. doi: 10.1513/AnnalsATS.202308-697RL.
2
Broad Adoption of Antifibrotics in Idiopathic Pulmonary Fibrosis: Still a Long Way to Go.
Ann Am Thorac Soc. 2021 Jul;18(7):1115-1116. doi: 10.1513/AnnalsATS.202102-123ED.
3
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
BMC Pulm Med. 2021 Jul 12;21(1):221. doi: 10.1186/s12890-021-01587-3.
4
Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias.
Respir Res. 2024 Jul 31;25(1):293. doi: 10.1186/s12931-024-02922-y.
5
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications.
BMC Pulm Med. 2021 Jul 17;21(1):239. doi: 10.1186/s12890-021-01607-2.
6
Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias?
Eur Respir J. 2021 Mar 18;57(3). doi: 10.1183/13993003.04562-2020. Print 2021 Mar.
7
Comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
Eur J Radiol. 2014 Oct;83(10):1988-9. doi: 10.1016/j.ejrad.2014.07.007. Epub 2014 Jul 18.
8
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries.
BMC Pulm Med. 2017 Sep 15;17(1):124. doi: 10.1186/s12890-017-0468-5.
9
Pharmacological therapy does not contribute to survival in idiopathic pulmonary fibrosis.
Respiration. 2013;86(1):86-7. doi: 10.1159/000348545. Epub 2013 Apr 9.
10
Treatments for idiopathic pulmonary fibrosis.
N Engl J Med. 2014 Aug 21;371(8):783-4. doi: 10.1056/NEJMc1407776.
引用本文的文献
1
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study.
BMC Pulm Med. 2025 May 8;25(1):221. doi: 10.1186/s12890-025-03689-8.
本文引用的文献
1
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis.
Respirology. 2023 Nov;28(11):1036-1042. doi: 10.1111/resp.14563. Epub 2023 Aug 3.
2
Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment.
BMC Pulm Med. 2023 Aug 2;23(1):281. doi: 10.1186/s12890-023-02565-7.
3
Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis.
Chest. 2023 Aug;164(2):441-449. doi: 10.1016/j.chest.2023.02.027. Epub 2023 Feb 18.
4
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
Chest. 2023 May;163(5):1156-1165. doi: 10.1016/j.chest.2022.12.039. Epub 2023 Jan 5.
5
Broad Adoption of Antifibrotics in Idiopathic Pulmonary Fibrosis: Still a Long Way to Go.
Ann Am Thorac Soc. 2021 Jul;18(7):1115-1116. doi: 10.1513/AnnalsATS.202102-123ED.
6
Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis.
Ann Am Thorac Soc. 2021 Jul;18(7):1121-1128. doi: 10.1513/AnnalsATS.202007-901OC.
7
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
Ann Am Thorac Soc. 2020 Nov;17(11):1413-1423. doi: 10.1513/AnnalsATS.201912-880OC.
8
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry.
Respir Res. 2020 Feb 10;21(1):48. doi: 10.1186/s12931-020-1315-4.
9
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
10
Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM.
Med Care. 2017 Dec;55(12):1046-1051. doi: 10.1097/MLR.0000000000000824.
Zotero 插件